Clarametyx

is an Ohio-based biotechnology company that researches and develops immune-enabling therapies for the treatment of genetic disorders...
Read more
Clarametyx CEO: David V. Richards

CEO

David V. Richards

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$56.9M

Clarametyx Competitors

1Orna
2Neuron23
3Graphite Bio
4GenEdit
5Secura Bio
6CRISPR
7Spark Therapeutics
8Beam
9Mozart
10Jounce

Trending Companies